Hcw biologics reports third quarter 2024 financial results and business highlights

Miramar, fla., nov. 14, 2024 (globe newswire) -- hcw biologics inc. (the “company” or “hcw biologics”) (nasdaq: hcwb), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its third quarter ended september 30, 2024.
HCWB Ratings Summary
HCWB Quant Ranking